KRT13 (Keratin, type I cytoskeletal 13) variants and mutations
KRT13 (also known as Keratin, type I cytoskeletal 13) is a human protein-coding gene encoding a keratin, type I cytoskeletal 13 protein. It contributes to intermediate filaments in non-keratinized stratified epithelia such as oral and esophageal mucosa. Dominant pathogenic variants can cause white sponge nevus, a benign disorder characterized by thickened white mucosal plaques. This analysis covers 838 KRT13 variants and mutations. Of these, 82% have computational variant effect predictions. Disease context includes White sponge nevus, hereditary disease, and neoplasm. Example KRT13 variants include R4C, R4G, and R4H.
Variant analysis overview
- Gene: KRT13
- Protein: Keratin, type I cytoskeletal 13
- UniProt accession: P13646
- Organism: Homo sapiens
- Variants analyzed: 838
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 592 unspecified-consequence records; 1 stop retained variant; 5 stop lost; 84 synonymous variants; 132 missense variants; 1 in-frame insertions; 5 in-frame deletions; 15 frameshift variants; 1 protein altering variant; 4 stop-gained variants; 3 splice-region variants; 1 substitution
- Prediction scores: 691 variants have prediction scores (82% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: White sponge nevus, hereditary disease, neoplasm, breast cancer, prostate carcinoma, breast carcinoma, prostate cancer, Familial prostate cancer, head and neck squamous cell carcinoma, hereditary gingival fibromatosis, rheumatoid arthritis, white sponge nevus 1.
Protein structure and variant hotspots
- Protein features: 1 domains; 3 post-translational modification sites.
- Structural context: 541 variants have structural context.
- PTM context: 8 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable KRT13 variants
Examples include R4C, R4G, R4H, R4L, L5R, Q6H, S7N, S9C. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- R4C (p.Arg4Cys), rs758585565, ClinGen CA8560891, cosmic curated COSV99877, ClinVar RCV004412189, REVEL 0.41, CADD 24.40, Uncertain significance, Inborn genetic diseases
- R4G (p.Arg4Gly), ExAC rs758585565, TOPMed rs758585565, gnomAD rs758585565, REVEL 0.37, CADD 19.70, Uncertain significance
- R4H (p.Arg4His), rs753767170, ClinGen CA8560890, cosmic curated COSV55840, ClinVar RCV002738395, REVEL 0.34, CADD 22.60, Uncertain significance, Inborn genetic diseases
- R4L (p.Arg4Leu), ExAC rs753767170, TOPMed rs753767170, gnomAD rs753767170, REVEL 0.28, CADD 22.40, Uncertain significance
- L5R (p.Leu5Arg), TOPMed rs1905037537
- Q6H (p.Gln6His), 1000Genomes rs146289936, TOPMed rs146289936, gnomAD rs146289936, REVEL 0.31, CADD 23.60
- S7N (p.Ser7Asn), rs1370565401, NCI-TCGA Cosmic COSV9987, cosmic curated COSV99877, gnomAD rs1370565401, REVEL 0.18, CADD 13.60, Variant assessed as somatic; moderate impact.
- S9C (p.Ser9Cys), Ensembl rs2144508992
- Y12C (p.Tyr12Cys), Ensembl rs1597766117, REVEL 0.29, CADD 24.40
- G14D (p.Gly14Asp), ExAC rs761496103, TOPMed rs761496103, gnomAD rs761496103, REVEL 0.32, CADD 22.90
- G14S (p.Gly14Ser), ExAC rs767264822, TOPMed rs767264822, gnomAD rs767264822, REVEL 0.11, CADD 17.50
- G15D (p.Gly15Asp), ExAC rs763544433, gnomAD rs763544433, REVEL 0.38, CADD 24.30
- G15S (p.Gly15Ser), ExAC rs774022235, TOPMed rs774022235, gnomAD rs774022235, REVEL 0.33, CADD 23.00
- G17R (p.Gly17Arg), ExAC rs770281794, TOPMed rs770281794, gnomAD rs770281794, REVEL 0.21, CADD 22.70
- G17W (p.Gly17Trp), ExAC rs770281794, TOPMed rs770281794, gnomAD rs770281794, REVEL 0.22, CADD 24.20
- G18D (p.Gly18Asp), 1000Genomes rs2144508939, REVEL 0.08, CADD 15.10
- G19D (p.Gly19Asp), ExAC rs746421136, gnomAD rs746421136, REVEL 0.49, CADD 24.80
- S20F (p.Ser20Phe), gnomAD rs1351013176, REVEL 0.34, CADD 22.80
- C21Y (p.Cys21Tyr), ExAC rs771244979, TOPMed rs771244979, gnomAD rs771244979, REVEL 0.37, CADD 22.30
- Q22R (p.Gln22Arg), ExAC rs747217763, REVEL 0.15, CADD 17.80
- L23M (p.Leu23Met), ExAC rs778165896, TOPMed rs778165896, gnomAD rs778165896, REVEL 0.27, CADD 23.60
- G24R (p.Gly24Arg), ExAC rs748231018, REVEL 0.44, CADD 25.20
- G25E (p.Gly25Glu), NCI-TCGA Cosmic COSV5584, cosmic curated COSV55841, REVEL 0.29, CADD 23.60, Variant assessed as somatic; moderate impact.
- G26D (p.Gly26Asp), ExAC rs779187731, TOPMed rs779187731, gnomAD rs779187731, REVEL 0.41, CADD 23.10
- R27C (p.Arg27Cys), rs756052301, ClinGen CA8560871, cosmic curated COSV55841, ClinVar RCV002895977, REVEL 0.15, CADD 22.90, Uncertain significance, Inborn genetic diseases
- R27H (p.Arg27His), rs140888301, ClinGen CA8560870, cosmic curated COSV55841, ClinVar RCV002850555, REVEL 0.18, CADD 22.50, Uncertain significance, Inborn genetic diseases
- G28D (p.Gly28Asp), ExAC rs780999432, REVEL 0.06, CADD 13.30
- V29A (p.Val29Ala), TOPMed rs1374117505, REVEL 0.13, CADD 18.10
- V29I (p.Val29Ile), gnomAD rs1157169159, REVEL 0.12, CADD 0.54
- S30A (p.Ser30Ala), gnomAD rs1457080671, REVEL 0.18, CADD 23.00
- S30C (p.Ser30Cys), gnomAD rs1413336225, REVEL 0.15, CADD 23.70
- C32R (p.Cys32Arg), ExAC rs763742361, TOPMed rs763742361, gnomAD rs763742361, REVEL 0.11, CADD 19.20
- S33* (p.Ser33Ter), TOPMed rs1313829910, gnomAD rs1313829910, CADD 36.00
- T34A (p.Thr34Ala), rs1905032825, ClinGen CA399488110, ClinVar RCV003303984, Ensembl rs1905032825, REVEL 0.10, CADD 6.57, Uncertain significance, Inborn genetic diseases
- T34P (p.Thr34Pro), Ensembl rs1905032825, Uncertain significance
- R35P (p.Arg35Pro), ExAC rs752191840, TOPMed rs752191840, gnomAD rs752191840
- R35Q (p.Arg35Gln), rs752191840, NCI-TCGA Cosmic COSV9987, cosmic curated COSV99877, ExAC rs752191840, REVEL 0.37, CADD 24.80, Variant assessed as somatic; moderate impact.
- R35W (p.Arg35Trp), rs762660600, ExAC rs762660600, TOPMed rs762660600, gnomAD rs762660600, REVEL 0.41, CADD 24.30, Uncertain significance, Inborn genetic diseases
- V37M (p.Val37Met), ExAC rs764706490, gnomAD rs764706490, REVEL 0.18, CADD 21.20
- S38A (p.Ser38Ala), TOPMed rs1905032243, gnomAD rs1905032243, REVEL 0.07, CADD 11.70
- S38C (p.Ser38Cys), ExAC rs777038018, gnomAD rs777038018
- S38F (p.Ser38Phe), ExAC rs777038018, gnomAD rs777038018
- G39R (p.Gly39Arg), rs1321449627, ClinGen CA399488083, ClinVar RCV002837249, TOPMed rs1321449627, REVEL 0.35, CADD 21.00, Uncertain significance, Inborn genetic diseases
- G40E (p.Gly40Glu), cosmic curated COSV55839, ExAC rs144144601, TOPMed rs144144601, gnomAD rs144144601, REVEL 0.38, CADD 18.80
- S41L (p.Ser41Leu), cosmic curated COSV55841, TOPMed rs1905031220
- G44D (p.Gly44Asp), TOPMed rs1254176560, REVEL 0.25, CADD 22.60
- Y45* (p.Tyr45Ter), TOPMed rs1905030933
- G46E (p.Gly46Glu), TOPMed rs1333018498, gnomAD rs1333018498, REVEL 0.40, CADD 19.90
- G48C (p.Gly48Cys), ExAC rs748425210, gnomAD rs748425210
- G48D (p.Gly48Asp), Ensembl rs1597765880
- G48S (p.Gly48Ser), ExAC rs748425210, gnomAD rs748425210, REVEL 0.27, CADD 7.69
- V49M (p.Val49Met), rs768649405, NCI-TCGA Cosmic COSV5584, cosmic curated COSV55840, ExAC rs768649405, REVEL 0.01, CADD 0.21, Variant assessed as somatic; moderate impact.
- S50G (p.Ser50Gly), Ensembl rs1224931150
- F53L (p.Phe53Leu), TOPMed rs1487168065
- G54A (p.Gly54Ala), ExAC rs781005051, TOPMed rs781005051, gnomAD rs781005051, REVEL 0.28, CADD 17.10
- G54D (p.Gly54Asp), ExAC rs781005051, TOPMed rs781005051, gnomAD rs781005051, REVEL 0.35, CADD 22.70
- G55A (p.Gly55Ala), ExAC rs757012196, gnomAD rs757012196, REVEL 0.19, CADD 13.60
- A57S (p.Ala57Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A57T (p.Ala57Thr), Ensembl rs1261980775
- A57V (p.Ala57Val), ExAC rs751353143, gnomAD rs751353143, REVEL 0.18, CADD 17.30
- G58S (p.Gly58Ser), ExAC rs777603079, gnomAD rs777603079, REVEL 0.28, CADD 18.60
- F61L (p.Phe61Leu), cosmic curated COSV10720, Ensembl rs1393841091, REVEL 0.13, CADD 13.70
- G62A (p.Gly62Ala), ExAC rs752390503, gnomAD rs752390503, REVEL 0.50, CADD 12.00
- G63C (p.Gly63Cys), NCI-TCGA Cosmic COSV5584, cosmic curated COSV55841, Variant assessed as somatic; moderate impact.
- G63D (p.Gly63Asp), ExAC rs758993002, TOPMed rs758993002, gnomAD rs758993002, REVEL 0.33, CADD 14.60
- G64V (p.Gly64Val), ExAC rs754317054, gnomAD rs754317054, REVEL 0.27, CADD 21.90
- Y65F (p.Tyr65Phe), NCI-TCGA Cosmic COSV9987, cosmic curated COSV99877, REVEL 0.08, CADD 1.22, Variant assessed as somatic; moderate impact.
- Y65H (p.Tyr65His), rs1001394879, NCI-TCGA Cosmic COSV9987, cosmic curated COSV99877, TOPMed rs1001394879, REVEL 0.10, CADD 14.30, Variant assessed as somatic; moderate impact.
- G67C (p.Gly67Cys), 1000Genomes rs141310122, ESP rs141310122, ExAC rs141310122, TOPMed rs141310122, Benign
- G67D (p.Gly67Asp), TOPMed rs1288521318, gnomAD rs1288521318, REVEL 0.15, CADD 12.10
- G67S (p.Gly67Ser), rs141310122, ClinGen CA8560840, ClinVar RCV000883452, 1000Genomes rs141310122, REVEL 0.05, CADD 2.68, Benign, not provided
- L69F (p.Leu69Phe), NCI-TCGA Cosmic COSV5583, cosmic curated COSV55839, Ensembl rs1905027092, Variant assessed as somatic; moderate impact.
- G71S (p.Gly71Ser), TOPMed rs1301274244, REVEL 0.30, CADD 8.52
- G71V (p.Gly71Val), ExAC rs762086095, TOPMed rs762086095, gnomAD rs762086095, REVEL 0.32, CADD 15.30
- G72C (p.Gly72Cys), ExAC rs774457214, TOPMed rs774457214, gnomAD rs774457214, REVEL 0.23, CADD 13.80
- Y73F (p.Tyr73Phe), cosmic curated COSV55840, gnomAD rs1359066454
- Y73H (p.Tyr73His), cosmic curated COSV55841, gnomAD rs1408063017, REVEL 0.05, CADD 15.00
- G74E (p.Gly74Glu), NCI-TCGA Cosmic COSV5584, cosmic curated COSV55840, Variant assessed as somatic; moderate impact.
- G75D (p.Gly75Asp), ExAC rs749334030, gnomAD rs749334030, REVEL 0.39, CADD 18.90
- G75R (p.Gly75Arg), ExAC rs768722370, TOPMed rs768722370, gnomAD rs768722370, REVEL 0.40, CADD 19.60
- L77F (p.Leu77Phe), ExAC rs770760776, REVEL 0.20, CADD 3.46
- F81V (p.Phe81Val), Ensembl rs1567714724, REVEL 0.19, CADD 8.05
- F81Y (p.Phe81Tyr), rs12150581, UniProt VAR 059376, Ensembl rs12150581, AlphaMissense 0.15, MetaLR 0.35
- G83E (p.Gly83Glu), NCI-TCGA TCGA novel, REVEL 0.37, CADD 21.60, Variant assessed as somatic; moderate impact.
- G84S (p.Gly84Ser), gnomAD rs1391681737, REVEL 0.10, CADD 16.00
- A86G (p.Ala86Gly), TOPMed rs920200832, gnomAD rs920200832, REVEL 0.06, CADD 5.13
- A86P (p.Ala86Pro), gnomAD rs1181490462, REVEL 0.11, CADD 15.70
- A86V (p.Ala86Val), TOPMed rs920200832, gnomAD rs920200832, REVEL 0.07, CADD 11.30
- G87A (p.Gly87Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G87R (p.Gly87Arg), ExAC rs746998705, TOPMed rs746998705, gnomAD rs746998705, REVEL 0.45, CADD 21.70
- G87S (p.Gly87Ser), cosmic curated COSV10801, ExAC rs746998705, TOPMed rs746998705, gnomAD rs746998705, REVEL 0.11, CADD 12.70, Uncertain significance, Inborn genetic diseases
- G88D (p.Gly88Asp), ESP rs140342847, ExAC rs140342847, TOPMed rs140342847, gnomAD rs140342847, REVEL 0.48, CADD 23.20
- F89V (p.Phe89Val), TOPMed rs1194879659, gnomAD rs1194879659, REVEL 0.18, CADD 16.10, Uncertain significance, Inborn genetic diseases
- D91N (p.Asp91Asn), NCI-TCGA Cosmic COSV5583, cosmic curated COSV55839, Variant assessed as somatic; moderate impact.
- A94S (p.Ala94Ser), Ensembl rs1597765616
- C95Y (p.Cys95Tyr), TOPMed rs1399321993
- D96G (p.Asp96Gly), TOPMed rs1905022424
- G98S (p.Gly98Ser), rs145116138, 1000Genomes rs145116138, ESP rs145116138, ExAC rs145116138, REVEL 0.06, CADD 16.10, Likely benign, not provided
- L99V (p.Leu99Val), gnomAD rs1300151420, REVEL 0.34, CADD 23.90
- L100F (p.Leu100Phe), TOPMed rs1455583196, REVEL 0.45, CADD 23.60
- L100P (p.Leu100Pro), gnomAD rs1905021716, REVEL 0.78, CADD 26.00
- T101A (p.Thr101Ala), ExAC rs753272265, gnomAD rs753272265
- T101I (p.Thr101Ile), TOPMed rs1285245754, gnomAD rs1285245754
- T101N (p.Thr101Asn), TOPMed rs1285245754, gnomAD rs1285245754, REVEL 0.23, CADD 18.20
- G102R (p.Gly102Arg), TOPMed rs1905021171, gnomAD rs1905021171, REVEL 0.58, CADD 24.00
- E104K (p.Glu104Lys), gnomAD rs1306847389, REVEL 0.93, CADD 28.40
- M108L (p.Met108Leu), ExAC rs756654902, TOPMed rs756654902, gnomAD rs756654902
- M108T (p.Met108Thr), rs60364670, ClinGen CA217667, ClinVar RCV000057205, UniProt VAR 016035, AlphaMissense 0.99, MetaLR 0.87, not provided
- Q109H (p.Gln109His), cosmic curated COSV55842, gnomAD rs1372015033, REVEL 0.82, CADD 24.30
- N110D (p.Asn110Asp), ExAC rs750997449, TOPMed rs750997449, gnomAD rs750997449
- N110K (p.Asn110Lys), ExAC rs767943356, gnomAD rs767943356, REVEL 0.73, CADD 25.40
- L111P (p.Leu111Pro), rs59897026, ClinGen CA151546, ClinVar RCV000057206, ClinVar RCV000116204, AlphaMissense 1.00, MetaLR 0.95, Pathogenic, White sponge nevus 2
- N112S (p.Asn112Ser), rs59970018, ClinGen CA217669, ClinVar RCV000057207, UniProt VAR 016036, AlphaMissense 0.92, MetaLR 0.95, not provided
- D113N (p.Asp113Asn), rs886052908, ClinGen CA10645621, NCI-TCGA Cosmic COSV5583, cosmic curated COSV55839, REVEL 0.67, CADD 25.50, Uncertain significance, White sponge nevus 2
- R114C (p.Arg114Cys), rs545085703, UniProt VAR 086269, TOPMed rs545085703, gnomAD rs545085703, REVEL 0.92, CADD 32.00, Uncertain significance, in WSN2
- R114H (p.Arg114His), rs267607388, ClinGen CA217671, cosmic curated COSV55840, ClinVar RCV000057208, REVEL 0.95, CADD 27.80, not provided
- L115M (p.Leu115Met), TOPMed rs772897754, gnomAD rs772897754, REVEL 0.79, CADD 23.90
- L115P (p.Leu115Pro), rs60906702, ClinGen CA217673, ClinVar RCV000057209, UniProt VAR 016037, AlphaMissense 1.00, MetaLR 0.91, not provided
- A116S (p.Ala116Ser), ESP rs376484003, ExAC rs376484003, TOPMed rs376484003, gnomAD rs376484003, REVEL 0.81, CADD 25.30, Uncertain significance, Inborn genetic diseases
- A116V (p.Ala116Val), 1000Genomes rs201949656, ExAC rs201949656, TOPMed rs201949656, gnomAD rs201949656, REVEL 0.90, CADD 29.20
- S117F (p.Ser117Phe), rs267604871, NCI-TCGA Cosmic COSV5583, cosmic curated COSV55839, gnomAD rs267604871, REVEL 0.57, CADD 23.80, Variant assessed as somatic; moderate impact.
- Y118* (p.Tyr118Ter), Ensembl rs1905019058, CADD 38.00
- Y118C (p.Tyr118Cys), NCI-TCGA Cosmic COSV9987, cosmic curated COSV99877, Variant assessed as somatic; moderate impact., in WSN2
- Y118D (p.Tyr118Asp), UniProt VAR 086271, Pathogenic, in WSN2
- L119M (p.Leu119Met), gnomAD rs1321451899, REVEL 0.64, CADD 24.70
- L119P (p.Leu119Pro), rs60440396, ClinGen CA124161, ClinVar RCV000015734, ClinVar RCV000057210, AlphaMissense 1.00, MetaLR 0.88, Pathogenic, White sponge nevus 2
- E120D (p.Glu120Asp), TOPMed rs905166177
- K121M (p.Lys121Met), rs1905018526, ClinGen CA399486983, ClinVar RCV002883642, TOPMed rs1905018526, REVEL 0.91, CADD 25.90, Uncertain significance, Inborn genetic diseases
- V122G (p.Val122Gly), NCI-TCGA Cosmic COSV5583, cosmic curated COSV55839, Variant assessed as somatic; moderate impact.
- R123C (p.Arg123Cys), cosmic curated COSV55840, ExAC rs775411186, TOPMed rs775411186, gnomAD rs775411186, REVEL 0.82, CADD 24.90, Uncertain significance, Inborn genetic diseases
- R123H (p.Arg123His), rs149866915, ClinGen CA8560811, ClinVar RCV002973087, ESP rs149866915, REVEL 0.59, CADD 17.10, Uncertain significance, Inborn genetic diseases
- R123S (p.Arg123Ser), ExAC rs775411186, TOPMed rs775411186, gnomAD rs775411186, REVEL 0.80, CADD 23.90
- A124D (p.Ala124Asp), Ensembl rs1567714641, REVEL 0.39, CADD 23.50
- A124S (p.Ala124Ser), ESP rs373485747, ExAC rs373485747, TOPMed rs373485747, gnomAD rs373485747
- A124T (p.Ala124Thr), cosmic curated COSV55840, ESP rs373485747, ExAC rs373485747, TOPMed rs373485747, REVEL 0.34, CADD 20.20
- L125M (p.Leu125Met), NCI-TCGA Cosmic COSV5584, cosmic curated COSV55840, Variant assessed as somatic; moderate impact.
- A128D (p.Ala128Asp), rs370135273, ClinGen CA8560808, ClinVar RCV004412190, ESP rs370135273, REVEL 0.62, CADD 23.40, Uncertain significance, Inborn genetic diseases
- N129D (p.Asn129Asp), gnomAD rs1457115259, REVEL 0.88, CADD 24.70
- N129S (p.Asn129Ser), ESP rs150899638, ExAC rs150899638, gnomAD rs150899638, REVEL 0.87, CADD 24.10
- A130T (p.Ala130Thr), rs1047174279, NCI-TCGA Cosmic COSV5584, cosmic curated COSV55840, TOPMed rs1047174279, REVEL 0.07, CADD 0.13, Variant assessed as somatic; moderate impact.
- A130V (p.Ala130Val), ExAC rs374240623, TOPMed rs374240623, gnomAD rs374240623, REVEL 0.31, CADD 22.70
- D131G (p.Asp131Gly), Ensembl rs1905016616, REVEL 0.37, CADD 22.20
- D131H (p.Asp131His), TOPMed rs200792420, gnomAD rs200792420
- D131N (p.Asp131Asn), cosmic curated COSV55841, TOPMed rs200792420, gnomAD rs200792420, REVEL 0.30, CADD 22.40
- D131Y (p.Asp131Tyr), TOPMed rs200792420, gnomAD rs200792420
- L132Q (p.Leu132Gln), ExAC rs755706974, gnomAD rs755706974, REVEL 0.97, CADD 26.40
- K135* (p.Lys135Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- R137C (p.Arg137Cys), rs142183272, ClinGen CA8560799, cosmic curated COSV55840, ClinVar RCV000314166, REVEL 0.61, CADD 27.20, Benign, White sponge nevus 2
- R137H (p.Arg137His), rs138959511, ClinGen CA8560798, cosmic curated COSV10720, ClinVar RCV002864115, REVEL 0.39, CADD 22.60, Uncertain significance, Inborn genetic diseases
- R137S (p.Arg137Ser), 1000Genomes rs142183272, ESP rs142183272, ExAC rs142183272, TOPMed rs142183272, REVEL 0.61, CADD 25.40, Benign
- D138E (p.Asp138Glu), gnomAD rs1224223882, REVEL 0.29, CADD 15.10
- W139* (p.Trp139Ter), NCI-TCGA Cosmic COSV9987, cosmic curated COSV99877, NCI-TCGA Cosmic COSV5583, cosmic curated COSV55839, CADD 38.00, Variant assessed as somatic; high impact.
- W139C (p.Trp139Cys), gnomAD rs1447201597
- H140Q (p.His140Gln), 1000Genomes rs530596803, ExAC rs530596803, TOPMed rs530596803, gnomAD rs530596803, Benign
- L141P (p.Leu141Pro), TOPMed rs1229563475, gnomAD rs1229563475, REVEL 0.36, CADD 2.59
- L141V (p.Leu141Val), ExAC rs763056747, gnomAD rs763056747, REVEL 0.33, CADD 20.10
- Q143E (p.Gln143Glu), rs2508649000, ClinGen CA399486576, ClinVar RCV003285960, REVEL 0.28, CADD 18.50, Uncertain significance, Inborn genetic diseases
- Q143L (p.Gln143Leu), NCI-TCGA Cosmic COSV5584, cosmic curated COSV55840, Variant assessed as somatic; moderate impact.
- S144N (p.Ser144Asn), cosmic curated COSV55840, TOPMed rs1004626014, gnomAD rs1004626014, REVEL 0.29, CADD 16.30
- S144R (p.Ser144Arg), Ensembl rs1905013882, REVEL 0.14, CADD 15.30
- P145S (p.Pro145Ser), cosmic curated COSV10455, TOPMed rs1905013716, gnomAD rs1905013716, REVEL 0.27, CADD 23.50
- A146D (p.Ala146Asp), 1000Genomes rs760134, ESP rs760134, ExAC rs760134, TOPMed rs760134, Benign
- A146G (p.Ala146Gly), rs760134, ClinGen CA8560795, cosmic curated COSV10801, ClinVar RCV000367695, REVEL 0.19, CADD 0.33, Benign, not provided; White sponge nevus 2
- A146S (p.Ala146Ser), TOPMed rs1905013425
- P148R (p.Pro148Arg), gnomAD rs1428376674, REVEL 0.41, CADD 23.70
- P148S (p.Pro148Ser), TOPMed rs1294981109, gnomAD rs1294981109, REVEL 0.39, CADD 22.00
- E149K (p.Glu149Lys), NCI-TCGA TCGA novel, TOPMed rs1905012017, REVEL 0.31, CADD 16.00, Variant assessed as somatic; moderate impact.
- R150L (p.Arg150Leu), 1000Genomes rs548070268, ExAC rs548070268, TOPMed rs548070268, gnomAD rs548070268, REVEL 0.42, CADD 20.40, Benign
- R150Q (p.Arg150Gln), rs548070268, ClinGen CA8560792, ClinVar RCV000313078, 1000Genomes rs548070268, REVEL 0.32, CADD 23.20, Benign, White sponge nevus 2
- R150W (p.Arg150Trp), cosmic curated COSV10801, ExAC rs759629819, TOPMed rs759629819, gnomAD rs759629819, REVEL 0.41, CADD 25.00, Uncertain significance, Inborn genetic diseases
- D151E (p.Asp151Glu), TOPMed rs1335027889
- D151G (p.Asp151Gly), Ensembl rs1905011036
- D151Y (p.Asp151Tyr), rs1458787161, NCI-TCGA Cosmic COSV5584, NCI-TCGA Cosmic COSV9987, cosmic curated COSV99877, REVEL 0.60, CADD 24.60, Variant assessed as somatic; moderate impact.
- Y152* (p.Tyr152Ter), Ensembl rs1905010724
- S153N (p.Ser153Asn), rs375114873, NCI-TCGA Cosmic COSV5584, cosmic curated COSV99877, ESP rs375114873, AlphaMissense 0.09, MetaLR 0.70, Variant assessed as somatic; moderate impact.
- S153R (p.Ser153Arg), ExAC rs771980528, gnomAD rs771980528, REVEL 0.57, CADD 20.10
- S153T (p.Ser153Thr), ESP rs375114873, TOPMed rs375114873
- P154L (p.Pro154Leu), TOPMed rs1165181435, gnomAD rs1165181435, REVEL 0.20, CADD 1.95
- P154S (p.Pro154Ser), ExAC rs773983288, gnomAD rs773983288, REVEL 0.08, CADD 0.05, Uncertain significance, Inborn genetic diseases
- P154T (p.Pro154Thr), ExAC rs773983288, gnomAD rs773983288, REVEL 0.08, CADD 0.15, Uncertain significance
Public KRT13 analysis runs
- KRT13 analysis run — KRT13 (838 variants) — completed 2026-08-22